Quarterly ResultAug 5, 2026, 02:03 PM
OrthoPediatrics Q2 Revenue $70.5M, Net Loss $(7.16)M
AI Summary
OrthoPediatrics Corp. reported a 15.4% increase in net revenue to $70.5 million for Q2 2026, with a net loss of $(7.16) million, similar to the prior year. The company significantly reduced its operating loss to $(4.07) million from $(10.66) million year-over-year. Year-to-date, net cash used in operating activities improved substantially to $(2.36) million from $(14.62) million. The company also continued its strategic acquisitions, including London Orthotic Consultancy and a UK medical device distributor.
Key Highlights
- Q2 2026 net revenue increased 15.4% to $70.5 million.
- Q2 2026 net loss was $(7.16) million, compared to $(7.11) million in Q2 2025.
- Q2 2026 operating loss improved to $(4.07) million from $(10.66) million.
- YTD 2026 net cash used in operating activities was $(2.36) million.
- Acquired London Orthotic Consultancy Consolidated Ltd in February 2026.
- Acquired a UK medical device distributor in April 2026.
- Total assets increased to $511.39 million as of June 30, 2026.
- Total stockholders' equity was $343.61 million as of June 30, 2026.
Price Impact
More from KIDS